OraSure Technologies
Top Five Articles on 360Dx Last Week: OraSure Restructuring; DiaSorin Divestiture; and More
Last week, readers were most interested in OraSure's plans to combine its Molecular Solutions and Diagnostics businesses and eliminate some positions.
OraSure Technologies Restructures Business as Q4 Revenues Nearly Double
The company is combining its Molecular Solutions and Diagnostics business units, a move that is expected to save it about $15 million annually.
Top Five Articles on 360Dx Last Week: Visby Gets FDA EUA; DoD Contract for COVID Tests; and More
Last week, readers were most interested in FDA awarding Emergency Use Authorization for Visby's point-of-care test for influenza A/B and COVID.
QuidelOrtho, Access Bio, iHealth, Orasure Nab DoD Contract for COVID-19 Antigen Tests
The companies will share the proceeds of the contract, worth up to $803 million, and provide the tests to HHS.
Earnings Roundup: OraSure Technologies, LumiraDx, Opko, More
OraSure, LumiraDx, Opko, and Epigenomics reported their financial results this week.
Jul 26, 2022
Feb 23, 2022
OraSure Technologies Q4 Revenues Grow 1 Percent
Feb 11, 2022
Nov 3, 2021
OraSure Technologies Q3 Revenues Rise 12 Percent
Sep 23, 2021
OraSure Technologies Nabs $13.6M BARDA Funding
May 5, 2021
OraSure Technologies Q1 Revenues Jump 85 Percent
Mar 3, 2021